These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

773 related items for PubMed ID: 23625156

  • 1. Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant.
    To KF, Tong JH, Yeung KS, Lung RW, Law PP, Chau SL, Kang W, Tong CY, Chow C, Chan AW, Leung LK, Mok TS.
    J Thorac Oncol; 2013 Jul; 8(7):883-91. PubMed ID: 23625156
    [Abstract] [Full Text] [Related]

  • 2. Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.
    Wallander ML, Geiersbach KB, Tripp SR, Layfield LJ.
    Arch Pathol Lab Med; 2012 Jul; 136(7):796-803. PubMed ID: 22742552
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic value of a novel fully automated immunochemistry assay for detection of ALK rearrangement in primary lung adenocarcinoma.
    Ying J, Guo L, Qiu T, Shan L, Ling Y, Liu X, Lu N.
    Ann Oncol; 2013 Oct; 24(10):2589-2593. PubMed ID: 23904459
    [Abstract] [Full Text] [Related]

  • 4. [ALK fusion gene assessment by fully automatic immunohistochemistry in non-small cell lung cancer].
    Guo L, Liu X, Qiu T, Ling Y, Shan L, Xie Y.
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):95-8. PubMed ID: 24742568
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Multiplex reverse transcription-PCR screening for EML4-ALK fusion transcripts.
    Takeuchi K, Choi YL, Soda M, Inamura K, Togashi Y, Hatano S, Enomoto M, Takada S, Yamashita Y, Satoh Y, Okumura S, Nakagawa K, Ishikawa Y, Mano H.
    Clin Cancer Res; 2008 Oct 15; 14(20):6618-24. PubMed ID: 18927303
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of IHC, FISH and RT-PCR methods for detection of ALK rearrangements in 312 non-small cell lung cancer patients in Taiwan.
    Wu YC, Chang IC, Wang CL, Chen TD, Chen YT, Liu HP, Chu Y, Chiu YT, Wu TH, Chou LH, Chen YR, Huang SF.
    PLoS One; 2013 Oct 15; 8(8):e70839. PubMed ID: 23951022
    [Abstract] [Full Text] [Related]

  • 9. Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.
    Boland JM, Erdogan S, Vasmatzis G, Yang P, Tillmans LS, Johnson MR, Wang X, Peterson LM, Halling KC, Oliveira AM, Aubry MC, Yi ES.
    Hum Pathol; 2009 Aug 15; 40(8):1152-8. PubMed ID: 19386350
    [Abstract] [Full Text] [Related]

  • 10. HIP1-ALK, a novel fusion protein identified in lung adenocarcinoma.
    Hong M, Kim RN, Song JY, Choi SJ, Oh E, Lira ME, Mao M, Takeuchi K, Han J, Kim J, Choi YL.
    J Thorac Oncol; 2014 Mar 15; 9(3):419-22. PubMed ID: 24518094
    [Abstract] [Full Text] [Related]

  • 11. The role of immunohistochemical analysis in the evaluation of EML4-ALK gene rearrangement in lung cancer.
    Sullivan HC, Fisher KE, Hoffa AL, Wang J, Saxe D, Siddiqui MT, Cohen C.
    Appl Immunohistochem Mol Morphol; 2015 Apr 15; 23(4):239-44. PubMed ID: 25265433
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A sensitive and high throughput TaqMan-based reverse transcription quantitative polymerase chain reaction assay efficiently discriminates ALK rearrangement from overexpression for lung cancer FFPE specimens.
    Lung J, Lin YC, Hung MS, Jiang YY, Lee KD, Lin PY, Tsai YH.
    Lung Cancer; 2016 Apr 15; 94():114-20. PubMed ID: 26973216
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer.
    Sanders HR, Li HR, Bruey JM, Scheerle JA, Meloni-Ehrig AM, Kelly JC, Novick C, Albitar M.
    Cancer Genet; 2011 Jan 15; 204(1):45-52. PubMed ID: 21356191
    [Abstract] [Full Text] [Related]

  • 18. The use of stained cytologic direct smears for ALK gene rearrangement analysis of lung adenocarcinoma.
    Betz BL, Dixon CA, Weigelin HC, Knoepp SM, Roh MH.
    Cancer Cytopathol; 2013 Sep 15; 121(9):489-99. PubMed ID: 23536384
    [Abstract] [Full Text] [Related]

  • 19. Detection of rearrangements and transcriptional up-regulation of ALK in FFPE lung cancer specimens using a novel, sensitive, quantitative reverse transcription polymerase chain reaction assay.
    Gruber K, Horn H, Kalla J, Fritz P, Rosenwald A, Kohlhäufl M, Friedel G, Schwab M, Ott G, Kalla C.
    J Thorac Oncol; 2014 Mar 15; 9(3):307-15. PubMed ID: 24495999
    [Abstract] [Full Text] [Related]

  • 20. TaqMan based real time PCR assay targeting EML4-ALK fusion transcripts in NSCLC.
    Robesova B, Bajerova M, Liskova K, Skrickova J, Tomiskova M, Pospisilova S, Mayer J, Dvorakova D.
    Lung Cancer; 2014 Jul 15; 85(1):25-30. PubMed ID: 24792336
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.